IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Isis Pharmaceuticals Inc

CUSIP: 464330959 | 7 institutional holders

Quarters

Q3 2015Q2 2015Q1 2015Q4 2014Q3 2014
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile